Full Text View
Tabular View
No Study Results Posted
Related Studies
Ph II Study of Azacitidine in Myelofibrosis
This study is ongoing, but not recruiting participants.
Study NCT00569660.   Last updated on December 10, 2007.
Information provided by M.D. Anderson Cancer Center
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Myelofibrosis
Additional conditions recognized in this trial
Myeloid Metaplasia
More general conditions related to this trial
Bone Marrow Diseases
Hematologic Diseases
Lymphatic Diseases
Myeloproliferative Disorders
Splenic Diseases
Interventions listed in this trial
Azacitidine
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
M.D. Anderson Cancer Center
Celgene Corporation


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services